48,868
edits
(→IHC) |
(→IHC) |
||
Line 37: | Line 37: | ||
Panel: | Panel: | ||
*CEA +ve (-ve in Bowen's disease, -ve in Toker cells). | *CEA +ve (-ve in Bowen's disease, -ve in Toker cells). | ||
*CK7 +ve. | *CK7 +ve. | ||
**Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month = | year = | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref> | **Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month = | year = | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref> | ||
*S100 -ve, HMB-45 -ve (both typically +ve in melanoma). | *S100 -ve, HMB-45 -ve (both typically +ve in melanoma). | ||
Line 45: | Line 45: | ||
*CK5/6 -ve.<ref>RS. May 2010.</ref> | *CK5/6 -ve.<ref>RS. May 2010.</ref> | ||
**Usu. +ve in [[squamous cell carcinoma]]. | **Usu. +ve in [[squamous cell carcinoma]]. | ||
*CAM 5.2 +ve. | |||
==See also== | ==See also== |
edits